Shorter drug course could reduce transplant side effects
NCT ID NCT06374095
Summary
This study compares two approaches to anti-rejection drugs after kidney transplant surgery. Researchers want to see if giving just one day of a powerful immune-suppressing drug works as well as giving it for seven days. They're looking at 75 kidney transplant patients to find out if the shorter treatment reduces side effects like infections and low blood counts while still preventing organ rejection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY REPLACEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST HPG23 - Unità di Nefrologia
Bergamo, BG, 24127, Italy
Conditions
Explore the condition pages connected to this study.